Research Comparison
Cagrilintide (AM833) vs Semaglutide
A side-by-side research comparison of Cagrilintide (AM833) and Semaglutide drawn from DRPSHP' peptide database records.
Cagrilintide (AM833)
Native human amylin is a poor research tool: the 37-residue hormone that pancreatic beta cells release alongside insulin aggregates readily and does not last long in circulation. Analogues are engineered to get round both problems, and Cagrilintide is one of them — a synthetic amylin analogue carrying a fatty-acid side chain that binds albumin in blood, which lengthened its half-life in pharmacokinetic studies. It is described as acting at amylin receptors and at the calcitonin receptor. Animal work was followed by human clinical trials in metabolic research, both of the compound alone and alongside a GLP-1 receptor agonist. Set against the literature on amylin itself, the published pharmacology of this analogue is recent and narrow.
Semaglutide
Semaglutide is best understood as human GLP-1 re-engineered so that it lasts. The native hormone is a 31-residue peptide destroyed in the bloodstream within a couple of minutes; semaglutide keeps the 31-residue frame but swaps in three changes, referenced to native numbering. Position 8 carries aminoisobutyric acid (Aib) so that dipeptidyl peptidase-4 cannot clip it, position 34 holds arginine instead of lysine, and the lysine at position 26 bears an 18-carbon diacid chain on a short spacer that lets the molecule ride on albumin. Receptor pharmacology, rodent models and a very extensive human trial record in metabolic disease all exist. A live question is how an albumin-bound molecule of this size reaches the brain regions where the receptor sits.
Reading a comparison
A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.